Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| 2-Methylcitric acid；Methylcitric acid | C7H10O7 | 6061-96-7 | Details |
| 2-Methylcitric acid trisodium；Methylcitric acid trisodium | C7H7O7*3Na | 117041-96-0 | Details |
| Estrone | C18H22O2 | 53-16-7 | Details |
| (1S,2S,3R)-DT-061 | C25H23F3N2O5S | 1809427-20-0 | Details |
| 24-Hydroxycholesterol | C27H46O2 | 30271-38-6 | Details |
| 20(S)-Hydroxycholesterol | C27H46O2 | 516-72-3 | Details |
| Cephalexin | C16H17N3O4S | 15686-71-2 | Details |
| DPP-IV-IN-1 | C11H18FN3O2 | 625110-37-4 | Details |
| Thrombin inhibitor 1 | C22H20Cl2F2N4O3 | 855998-46-8 | Details |
| PF-592379 | C13H21N3O | 710655-15-5 | Details |
| (2R,4R)-APDC | C6H10N2O4 | 169209-63-6 | Details |
| (2R,3S)-E1R | C13H16N2O2 | 1424832-60-9 | Details |
| A2B receptor antagonist 1 | C21H24N6O2 | 531506-36-2 | Details |
| DT-061 | C25H23F3N2O5S | 1809427-19-7 | Details |
| (-)-GSK598809；1S,5R-GSK598809 | C22H23F4N5OS | 863680-46-0 | Details |
| 2',5'-Dideoxyadenosine | C10H13N5O2 | 6698-26-6 | Details |
| 2-O-β-D-Glucopyranosyl-L-ascorbic acid；AA-2βG | C12H18O11 | 562043-82-7 | Details |
| MAO-IN-1 | C17H19ClO4 | 124991-40-8 | Details |
| E1R | C13H16N2O2 | 1301211-78-8 | Details |
| (2R,3R)-E1R | C13H16N2O2 | 1400888-63-2 | Details |
| PSN-GK1 | C20H23FN2O4S2 | 745051-61-0 | Details |
| Anti-inflammatory agent 1 | C17H16O3S | 1096621-42-9 | Details |
| CRTh2 antagonist 1 | C23H25N3O5S | 1379445-54-1 | Details |
| 2614W94 | C15H11F3O4S | 205187-35-5 | Details |
| 24-Norursodeoxycholic acid | C23H38O4 | 99697-24-2 | Details |
| 24R-Calcipotriol；PRI 2202 | C27H40O3 | 112827-99-3 | Details |
| LDL-IN-3 | C24H36O3Si | 180908-67-2 | Details |
| Nanofin | C7H15N | 504-03-0 | Details |
| 2',3'-cGAMP；2'-3'-cyclic GMP-AMP | C20H24N10O13P2 | 1441190-66-4 | Details |
| 2',5-Difluoro-2'-deoxycytidine | C9H11F2N3O4 | 581772-30-7 | Details |
| AMPK activator 1 | C32H33F3N4O3 | 1152423-98-7 | Details |
| 2'-Azido-2'-deoxyuridine；N3dUrd | C9H11N5O5 | 26929-65-7 | Details |
| 2'-Ethyl Simvastatin | C23H34O5 | 79902-42-4 | Details |
| 2-Hydroxy Ibuprofen；(±)-2-Hydroxy Ibuprofen | C13H18O3 | 51146-55-5 | Details |
| 2-Keto-D-Glucose；D-Glucosone | C6H10O6 | 1854-25-7 | Details |
| Itch-Targeting Compound 1 | C25H36ClN3O3 | 793674-76-7 | Details |
| 2-Methyl-5-HT；2-Methyl-5-hydroxytryptamine | C11H14N2O | 78263-90-8 | Details |
| Amoxicillin trihydrate | C16H21N3O6S | 61336-70-7 | Details |
| (1S,2S)-Bortezomib | C19H25BN4O4 | 1132709-14-8 | Details |
| Propantheline bromide | C23H30BrNO3 | 50-34-0 | Details |
| 2-Iodomelatonin | C13H15IN2O2 | 93515-00-5 | Details |
| LH secretion antagonist 1 | C18H24ClNO2 | 88531-67-3 | Details |
| Neuromuscular Disorder-Targeting Compound 1 | C15H25N3S | 374538-23-5 | Details |
| 2-Methyl-5-HT maleate；2-Methylserotonin maleate;2-Methyl-5-hydroxytryptamine maleate;2-Me-HT maleate | C15H18N2O5 | 78263-91-9 | Details |
| 2-Methyl-5-HT hydrochloride；2-Methyl-5-hydroxytryptamine hydrochloride | C11H15ClN2O | 845861-49-6 | Details |
| 2'-Deoxypseudoisocytidine | C9H13N3O4 | 65358-18-1 | Details |
| PGS-IN-1 | C19H26O3 | 102271-49-8 | Details |
| (2S,3S)-E1R | C13H16N2O2 | 1424832-57-4 | Details |
| Verapamil hydrochloride | C27H39ClN2O4 | 152-11-4 | Details |
| 3,4-Dihydroxybenzylamine hydrobromide | C7H10BrNO2 | 16290-26-9 | Details |
| 3,3'-Diiodo-L-thyronine；3,3'-T2 | C15H13I2NO4 | 4604-41-5 | Details |
| Calcium channel-modulator-1 | C26H24Cl2N2O7S | 136941-70-3 | Details |
| QF0301B | C23H28N2O2 | 149247-12-1 | Details |
| Amikacin | C22H43N5O13 | 37517-28-5 | Details |
| 3α-Hydroxymogrol | C30H52O4 | 1343402-73-2 | Details |
| 3-arylisoquinolinamine derivative | C18H19N3O | 1029008-71-6 | Details |
| 3-Deazaadenosine | C11H14N4O4 | 6736-58-9 | Details |
| 3-Hydroxy agomelatine D3 | C15H17NO3 | 1079774-23-4 | Details |
| 3-Hydroxy agomelatine | C15H17NO3 | 166526-99-4 | Details |
| 3-O-Methyltolcapone；Ro 40-7591 | C15H13NO5 | 134612-80-9 | Details |
| 4-Acetamidophenyl acetate | C10H11NO3 | 2623-33-8 | Details |
| (3R,5S)-Atorvastatin sodium | C33H34FN2O5.Na | 131275-93-9 | Details |
| (3S,5R)-Fluvastatin D6 sodium；(3S,5R)-XU 62-320 D6 | C24H27FNNaO4 | 2249799-35-5 | Details |
| (3S,5R)-Fluvastatin sodium；(3S,5R)-XU 62-320 | C24H25FNNaO4 | 94061-81-1 | Details |
| (3S,5R)-Pitavastatin calcium | C25H26CaFNO4 | 254452-88-5 | Details |
| Acebutolol hydrochloride | C18H29ClN2O4 | 34381-68-5 | Details |
| (3R,5R)-Rosuvastatin | C22H28FN3O6S | 1094100-06-7 | Details |
| VEGFR-2-IN-9；KDR-in-4 | C23H25N3O3 | 408502-06-7 | Details |
| (3R,4R)-A2-32-01 | C19H27NO2 | 1359752-95-6 | Details |
| Anti-neurodegeneration agent 1 | C14H20ClN3O3 | 289893-23-8 | Details |
| Substance P Receptor Antagonist 1 | C24H29F3N2O2 | 225526-17-0 | Details |
| 3-O-Acetylbufotalin | C28H38O7 | 4029-69-0 | Details |
| 3-Oxo Atorvastatin | C33H33FN2O5 | 887196-30-7 | Details |
| 3-Hydroxy-4-methoxyacetophenone | C9H10O3 | 6100-74-9 | Details |
| 3-CPs | C14H10O5 | 20073-24-9 | Details |
| Itraconazole | C35H38Cl2N8O4 | 84625-61-6 | Details |
| 3-Bromo-7-nitroindazole | C7H4BrN3O2 | 74209-34-0 | Details |
| Antiulcer Agent 1 | C19H23N3O4 | 76001-09-7 | Details |
| 3'-O-Acetylhamaudol | C17H18O6 | 30358-88-4 | Details |
| 3-Deazaadenosine hydrochloride | C11H15ClN4O4 | 86583-19-9 | Details |
| 3-Carene | C10H16 | 13466-78-9 | Details |
| 3-Bromocytisine | C11H13BrN2O | 207390-14-5 | Details |
| 3'-Azido-3'-deoxy-5-methylcytidine | C10H14N6O4 | 1282040-14-5 | Details |
| 4,7,10,13,16-Docosapentaenoic acid | C22H34O2 | 2313-14-6 | Details |
| (3S,5S)-Pitavastatin calcium | C25H26CaFNO4 | 254452-92-1 | Details |
| (3S,5R)-Rosuvastatin | C22H28FN3O6S | 1242184-42-4 | Details |
| 4'-Ethynyl-2'-deoxyadenosine | C12H13N5O3 | 306305-07-7 | Details |
| 4-Hydroxyacetophenone oxime | C8H9NO2 | 34523-34-7 | Details |
| p-Ethynylphenylalanine | C11H11NO2 | 278605-15-5 | Details |
| 4-Acetylsimvastatin | C27H40O6 | 145576-25-6 | Details |
| 4-Diethylaminobenzaldehyde | C11H15NO | 120-21-8 | Details |
| 4-Desmethoxy Omeprazole | C16H17N3O2S | 110374-16-8 | Details |
| 4-Desmethyl Istradefylline | C19H22N4O4 | 160434-48-0 | Details |
| 4-Hydroxyatomoxetine | C17H21NO2 | 435293-66-6 | Details |
| 4-Hydroxyatomoxetine D3 | C17H21NO2 | 1217686-14-0 | Details |
| 4-Bromo A23187；4-?Bromo A23187 | C29H36BrN3O6 | 76455-48-6 | Details |
| 3-Nitrocoumarin | C9H5NO4 | 28448-04-6 | Details |
| (2S,3R)-Voruciclib | C22H19ClF3NO5 | 1253731-24-6 | Details |
| 264W94 | C23H31NO4S | 178961-24-5 | Details |
| Desethyl KBT-3022 | C23H20N2O4S | 101001-72-3 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 | ||||